ACTIVE SUBSTANCE / INN

TELITHROMYCIN

Brand name(s): KETEK, Levviax, Ketek
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
Community-Acquired Infections;Pharyngitis;Bronchitis, Chroni…
Sinusitis;Tonsillitis;Bronchitis, Chronic;Pharyngitis;Commun…
ACTIVE SUBSTANCE
Telithromycin
REGULATORS
FDA · EMA
SPONSORS / MAH
Aventis Pharma S.A., SANOFI AVENTIS US
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KETEKNDA021144SANOFI AVENTIS USDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KetekAventis Pharma S.A.Withdrawn09/07/2001Sinusitis;Tonsillitis;Bronchitis, Chronic;Pharyngitis;Community-Acquired Infecti…
LevviaxAventis Pharma S.A.Withdrawn09/07/2001Community-Acquired Infections;Pharyngitis;Bronchitis, Chronic;Pneumonia;Tonsilli…

FULL INTELLIGENCE ON TELITHROMYCIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →